Y-mAbs Therapeutics, Inc. (YMAB) Q1 2025 Earnings Call Transcript

Y-mAbs Therapeutics, Inc. (YMAB) Q1 2025 Earnings Call Transcript #YmAbs #Therapeutics #YMAB #Earnings #Call #Transcript

Y-mAbs Presents Translational Pharmacokinetics of CD38-SADA from Pretargeted RIT Platform at 2025 American Association for Cancer Research (AACR) Annual Meeting

Y-mAbs Presents Translational Pharmacokinetics of CD38-SADA from Pretargeted RIT Platform at 2025 American Association for Cancer…

Y-mAbs Therapeutics: A Yawn From The Market Means Opportunity

Y-mAbs Therapeutics: A Yawn From The Market Means Opportunity #YmAbs #Therapeutics #Yawn #Market #Means #Opportunity

Y-mAbs Therapeutics: Finding Direction Through The Murk Of Clinical Trials

Y-mAbs Therapeutics: Finding Direction Through The Murk Of Clinical Trials #YmAbs #Therapeutics #Finding #Direction #Murk #Clinical…